Orthogonally Engineered Bacteria Capture Metabolically Labeled Tumor Antigens to Improve the Systemic Immune Response in Irradiated Tumors
ACS Nano · 11.02.2025 · 19 (5) · 5376-5391
DOI: 10.1021/acsnano.4c13320 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 31.01.2025. Verfasst von Wen Xia und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Pharmaceutical Biotechnology, Medical School of Nanjing University, Nanjing 210093, China. Hauptthemen laut MEDLINE: Antigens, Neoplasm, Cancer Vaccines, Salmonella. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, National Natural Science Foundation of China, Special Funds of Life and Health Technology of Nanjing.
Abstract (Originalsprache)
In situ vaccination is considered a promising cancer immunotherapy strategy to elicit a tumor-specific T cell response. Live bacteria effectively enhanced the immune response in irradiated tumors as it can activate multiple immune cells. However, the adaptive immune response remains low since bacteria lack the efficient delivery of antigen to dendritic cells (DCs). Here, we show that tumor antigens can be metabolically labeled with azido groups in situ, allowing for their specific capture by orthogonally engineered Salmonella via bioorthogonal chemistry. Subsequently, these antigens are efficiently delivered to DCs through the active movement of the bacteria. Intratumorally injected engineered bacteria captured the labeled antigens and improved their presentation by DCs. This increased the proportion of antigen-specific CD8+ T cells in tumors, further resulting in systemic antitumor effects in the bilateral melanoma mouse model. The antitumor effects were abrogated in Batf3-/- mice or after CD8+ T cell depletion, indicating that systemic antitumor effects were dependent on adaptive immune responses. Overall, our work presents a strategy combining bacterial engineering and antigen labeling, which may guide the development of in situ vaccines in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Pharmaceutical Biotechnology, Medical School of Nanjing University, Nanjing 210093, China.
- Department of Andrology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, No. 321 Zhongshan Road, Gulou District, Nanjing 210008, China.
- Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing 210093, China.
- Chemistry and Biomedicine Innovation Center, Nanjing University, Nanjing 210023, China.
- Institute of Drug Research and Development & Jiangsu Engineering Center of Biointelligent Materials, Nanjing University, Nanjing 210093, China.
- Wuxi Xishan NJU Institute of Applied Biotechnology, Anzhen Street, Xishan District, Wuxi 214101, China.
Förderung
- Ministry of Science and Technology of the People's Republic of China
- National Natural Science Foundation of China
- Special Funds of Life and Health Technology of Nanjing
- Central Guidance for Local Science and Technology Development Funds Project
- National Natural Science Foundation of the People's Republic of China
Zitieren
APA
Xia, W., Feng, Z., Wang, Y., Lei, R., Zhou, Y., Zhuo, Y., Xie, R., Dong, H., Zhao, X., Guan, X., & Wu, J. (2025). Orthogonally Engineered Bacteria Capture Metabolically Labeled Tumor Antigens to Improve the Systemic Immune Response in Irradiated Tumors. ACS Nano, 19(5), 5376-5391. https://doi.org/10.1021/acsnano.4c13320
Vancouver
Xia W, Feng Z, Wang Y, Lei R, Zhou Y, Zhuo Y, et al. Orthogonally Engineered Bacteria Capture Metabolically Labeled Tumor Antigens to Improve the Systemic Immune Response in Irradiated Tumors. ACS Nano. 2025;19(5):5376-5391. doi:10.1021/acsnano.4c13320
BibTeX
@article{Xia2025,
author = {Xia, Wen and Feng, Zhuo and Wang, Yuchen and Lei, Ruiqi and Zhou, Yao and Zhuo, Yujia and Xie, Ran and Dong, Hong and Zhao, Xiaozhi and Guan, Xiaoxiang and Wu, Jinhui},
title = {Orthogonally Engineered Bacteria Capture Metabolically Labeled Tumor Antigens to Improve the Systemic Immune Response in Irradiated Tumors},
journal = {ACS Nano},
year = {2025},
volume = {19},
number = {5},
pages = {5376--5391},
doi = {10.1021/acsnano.4c13320}
}
EUVIMED